| Liver physiology and pathology | Lifetime | 24 | DE 5 | 99.63 |
| Liver Disease Diagnosis and Treatment | Lifetime | 179 | DE 15 | 99.71 |
| Connective Tissue Growth Factor Research | Lifetime | 16 | DE 2 | 98.70 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 138 | DE 11 | 98.78 |
| TGF-β signaling in diseases | Lifetime | 93 | DE 5 | 97.96 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 387 | DE 28 | 97.40 |
| Trace Elements in Health | Lifetime | 442 | DE 23 | 97.39 |
| Macrophage Migration Inhibitory Factor | Lifetime | 81 | DE 11 | 96.64 |
| Liver Diseases and Immunity | Lifetime | 300 | DE 22 | 97.64 |
| Heavy Metal Exposure and Toxicity | Lifetime | 672 | DE 20 | 96.23 |
| Acute Kidney Injury Research | Lifetime | 862 | DE 49 | 92.99 |
| Liver physiology and pathology | 2021-2025 | 3 | DE 2 | 99.57 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 90 | DE 6 | 99.49 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 12 | DE 2 | 98.26 |
| Digestive system and related health | 2021-2025 | 6 | DE 1 | 97.24 |
| Lipid metabolism and biosynthesis | 2021-2025 | 16 | DE 2 | 96.15 |
| Trace Elements in Health | 2021-2025 | 59 | DE 6 | 95.35 |
| Iron Metabolism and Disorders | 2021-2025 | 119 | DE 5 | 95.12 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 31 | DE 7 | 93.55 |
| RNA Interference and Gene Delivery | 2021-2025 | 541 | DE 19 | 92.79 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 478 | DE 19 | 93.41 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 343 | DE 19 | 90.27 |
| Acute Kidney Injury Research | 2021-2025 | 236 | DE 9 | 91.03 |
| Diet, Metabolism, and Disease | 2021-2025 | 375 | DE 12 | 90.71 |
| Liver Diseases and Immunity | 2021-2025 | 309 | DE 14 | 89.64 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 483 | DE 30 | 83.93 |
| Heavy Metal Exposure and Toxicity | 2021-2025 | 568 | DE 14 | 85.73 |
| Electrolyte and hormonal disorders | 2021-2025 | 256 | DE 16 | 82.01 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 542 | DE 37 | 81.07 |
| Connective Tissue Growth Factor Research | 2021-2025 | 33 | DE 2 | 82.49 |
| Estrogen and related hormone effects | 2021-2025 | 579 | DE 15 | 77.71 |
| Apelin-related biomedical research | 2021-2025 | 128 | DE 1 | 74.42 |
| Pharmacology and Obesity Treatment | 2021-2025 | 470 | DE 20 | 73.08 |
| Lipid metabolism and disorders | 2021-2025 | 489 | DE 7 | 71.23 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 615 | DE 31 | 66.21 |
| Cell death mechanisms and regulation | 2021-2025 | 525 | DE 24 | 56.45 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 259 | DE 23 | 57.89 |
